Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 1967929.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fifty patients with typical infiltrating ductal adenocarcinoma of the breast were studied for amplification of the c-erb B-2 (neu/HER-2) oncogene within the tumor DNA. Amplification, ranging from 4 to greater than 50 copies per cell, was observed in 17 (34%) of the samples. The presence of c-erb B-2 gene amplification was not significantly correlated with patient survival, metastases, recurrence, or overall histologic grade. However, amplification was significantly associated with increased mitotic activity. Also, amplification of c-erb B-2 showed a significantly negative association with both progesterone and estrogen receptor presence. Progesterone receptor presence correlated significantly with survival.
Medical subject headings
- Biomarkers, Tumor
- Breast Neoplasms
- Carcinoma, Intraductal, Noninfiltrating
- DNA, Neoplasm
- Proto-Oncogene Proteins